News Conference News TCT 2016 Novel SES Fails to Match Xience EES for Chronic Total Occlusions Yael L. Maxwell November 08, 2016
News Conference News TCT 2016 RIBS VI: El SVB Absorb es Seguro en el Manejo de la Reestenosis Intra-stent pero No Supera al Stent Metálico Xience Michael O'Riordan November 08, 2016
News Conference News TCT 2016 RIBS VI: Absorb BVS Safe in In-Stent Restenosis but Fails to Best Xience Metallic Stent Michael O'Riordan November 08, 2016
News Opinion Editor's Corner TCT 2016 My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway Shelley Wood November 07, 2016
News Opinion Editor's Corner TCT 2016 Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones Shelley Wood November 07, 2016
News Conference News TCT 2016 No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low Shelley Wood November 07, 2016
News Industry News Positive Five-Year Clinical Data from Micell Technologies’ MiStent Presented at TCT 2016 November 03, 2016
News Industry News TCT 2016 Imaging Study Shows Rate of Strut Coverage and Low Rates of Neouatherosclerosis with Thin Strut Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents November 02, 2016
News Industry News TCT 2016 Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions November 02, 2016
News Conference News TCT 2016 TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES Michael O'Riordan November 02, 2016
News Conference News TCT 2016 TRANSFORM-OCT: Similar Curación Precoz y Tardía con SLF Bioreabsorbibles y de Polímero Duradero Michael O'Riordan November 02, 2016
Presentation TCT 2016 TRANSFORM-OCT: A Prospective, Randomized Trial Using OCT Imaging to Evaluate Strut Coverage at Three Months and Neoatherosclerosis at Eighteen Months in Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents Presenter: Gary S. Mintz, Robert-Jan van Geuns, Giulio Guagliumi November 02, 2016
Presentation TCT 2016 Highlights (and my Interpretations) From: PLATINUM DIVERSITY Presenter: Philip M. Urban, Stephen G. Worthley, Bonnie H. Weiner November 01, 2016
Presentation TCT 2016 Highlights (and My Interpretations) From: Absorb BVS - ABSORB II and ABSORB China (2-3 Year Results) Presenter: Philip M. Urban, Stephen G. Worthley, Stephen G. Ellis November 01, 2016
Presentation TCT 2016 Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6-9 Month Results) Presenter: Philip M. Urban, Stephen G. Worthley, Robert-Jan van Geuns November 01, 2016
Presentation TCT 2016 Bare Metal and 1st Generation Drug-Eluting Stents: Devices, Indications, and Outcomes Presenter: Dmitriy N. Feldman, Emmanouil S. Brilakis November 01, 2016
Presentation TCT 2016 Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution Presenter: Philip M. Urban, Stephen G. Worthley, Christian M. Spaulding November 01, 2016
Presentation TCT 2016 Highlights (And my Interpretations) From: DES Comparisons BIO-RESORT (TWENTE III) and BIONICS Presenter: Philip M. Urban, Stephen G. Worthley, Sigmund Silber November 01, 2016
News Conference News TCT 2016 ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events Michael O'Riordan November 01, 2016
Presentation TCT 2016 TCT 313: Incidence and Predictors of Very Late Major Adverse Cardiac Events After Metallic Stents: A Patient-Level Pooled Analysis from Seventeen Randomized Trials Presenter: Serban Puricel, Clemens von Birgelen November 01, 2016